Yes, TRXF11 is considered one of the best brick-and-mortar REITs in Brazil. The Rico aos Poucos analysis assigned a rating of 8.5 out of 10 and a BUY verdict. The fund ranks second among the ten peers analyzed in the high-quality brick-and-mortar-with-logistics segment, alongside BTLG11, BRCO11 and HSLG11.
The central argument is simple: TRXF11 delivers a rare combination of predictability and quality — 124 properties spread across 17 states, with 73.4% of revenue in long-term atypical contracts (WAULT of 13.2 years) and physical vacancy of just 0.67%. With the unit trading at P/BV of 0.93 — that is, 6.6% below book value — and a DY of 12.16%, the risk-reward relationship looks favorable for the investor with a medium-to-long-term horizon.
That said, the buy verdict does not mean an absence of risks. There are real points of attention that any investor should understand before taking a position — and that are explained in depth throughout this analysis.
TRXF11 was built to generate stable monthly income protected by IPCA, not for aggressive dividend growth. Before buying, it is worth asking whether this profile makes sense for you:
There is a frequent confusion in TRXF11 analyses: the Management Report aggregates under the "Pão de Açúcar (GPA)" line a historical block of 24.24% of revenue. That number included, before 2021, contracts with the entire group. After the spin-off of Assaí (ASAI3) from GPA, the reality changed:
Other relevant points of attention:
The fair value calculated by the Rico aos Poucos methodology is R$ 99.17/unit, with a range of R$ 92.23 to R$ 106.11. With the unit trading around R$ 91.37, the discount to the estimated fair value is about 8% — a modest margin of safety for an institutional-quality fund.
Three methodologies make up the calculation:
The fair value of R$ 99.17 takes into account a quality factor of 0.945, which positively weighs the manager TRX (top 3 in the segment), the 0.46% vacancy, the 12-year WAULT and DPS stability. Selic at 14.75% is the main factor keeping fair value depressed relative to book value. If Selic falls to 11% (the Focus 12-month projection), fair value should rise to R$ 105 or more — generating appreciation potential on top of the current DY.
TRXF11 deserves the 8.5 rating and the buy verdict for a combination that few funds manage to assemble: scale, real diversification, a top-tier manager and contracts that protect the unitholder for an entire decade. In June 2026, the unit was 6.6% below book value (P/BV 0.93), the embedded DY was about 12.16% and the manager reiterated guidance of R$ 0.90 to R$ 0.93 through December 2026.
The short-term catalysts are concrete: the sale of 9 properties was completed in June 2026, with an extraordinary distribution expected between R$ 1.30 and R$ 1.80/unit; the delivery of Hospital Albert Einstein is scheduled for July; and the Selic-easing cycle projected for the next 12-24 months tends to compress the DY-Selic spread and reprice brick-and-mortar REITs upward.
For the long-term investor focused on income, TRXF11 works as a REIT portfolio core that combines inflation protection, monthly cash-flow predictability and exceptional liquidity. It is not the cheapest fund nor the one that will deliver the greatest DPS growth — but it is probably the most reliable in the urban-income segment. Those seeking just one brick-and-mortar REIT to anchor the portfolio find here one of the best options available on B3. Information on monthly dividends and the live price of TRXF11 is available in dedicated sections of this platform.
TRXF11 is considered a good brick-and-mortar REIT. It received a 8.5 rating and a BUY verdict in the Rico aos Poucos analysis, for combining 124 properties, a WAULT of 13.2 years, vacancy of 0.67% and a DY of 12.16%. It is suitable for those seeking predictable monthly income with inflation protection.
Yes, for the income profile. In 2026, the fund has a P/BV of 0.93 (6.6% below book value), a DY of 12.16% and confirmed guidance of R$ 0.90 to R$ 0.93/unit through December. Near-term catalysts include completion of the sale of 9 properties and the delivery of two hospitals.
The calculated fair value is R$ 99.17/unit (range of R$ 92.23 to R$ 106.11). With the unit around R$ 91.37, the discount is about 8%. In a scenario of Selic falling to 11%, fair value should rise to R$ 105 or more.
The main risk is the 7.8% revenue exposure to PCAR3 (Pão de Açúcar) in out-of-court reorganization — not 24%, since the other 16.4% of the GPA block is Assaí, an independent company with investment grade. Other risks: a possible new unit offering with dilution and execution of the hospital construction.
Buy, according to the Rico aos Poucos analysis (8.5 rating). It makes sense for an income investor with a medium-to-long-term horizon. It is not suitable for those seeking aggressive DPS growth or who want to avoid any exposure to retail under debt renegotiation.
It depends on the goal. GARE11 is more discounted (lower P/BV) with greater appreciation potential if Selic falls, but has a smaller portfolio. TRXF11 is larger, more diversified (124 properties vs GARE11's smaller portfolio) and with a superior WAULT. For a portfolio core, TRXF11; for a discount trade, GARE11.